Targeting NRG1-fusions in lung adenocarcinoma: Afatinib as a novel potential treatment strategy Meeting Abstract


Authors: Duruisseaux, M.; Laskin, J. J.; Tolba, K.; Branden, E.; Goto, Y.; Doebele, R.; Cheema, P. K.; Cadranel, J.; Jones, M. R.; Drilon, A.; Trombetta, D.; Muscarella, L. A.; Cseh, A.; Solca, F.; Liu, S.
Abstract Title: Targeting NRG1-fusions in lung adenocarcinoma: Afatinib as a novel potential treatment strategy
Meeting Title: 20th World Conference on Lung Cancer of the International Association for the Study of Lung Cancer (IASLC)
Journal Title: Journal of Thoracic Oncology
Volume: 14
Issue: 10 Suppl.
Meeting Dates: 2019 Sept 7-10
Meeting Location: Barcelona, Spain
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2019-10-01
Start Page: S563
Language: English
ACCESSION: WOS:000492162203092
DOI: 10.1016/j.jtho.2019.08.1176
PROVIDER: wos
Notes: Meeting Abstract: P1.14-25 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon